Literature DB >> 28794878

Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12-13 May 2017.

Peter L Stern1.   

Abstract

Entities:  

Year:  2017        PMID： 28794878      PMCID： PMC5524245          DOI： 10.1177/2051013617720659

Source DB:  PubMed          Journal:  Ther Adv Vaccines        ISSN： 2051-0136


× No keyword cloud information.
  65 in total

1.  Rapid eradication of a bulky melanoma mass with one dose of immunotherapy.

Authors:  Paul B Chapman; Sandra P D'Angelo; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2015-04-20       Impact factor: 91.245

2.  Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697).

Authors:  Lisa H Butterfield; Fengmin Zhao; Sandra Lee; Ahmad A Tarhini; Kim A Margolin; Richard L White; Michael B Atkins; Gary I Cohen; Theresa L Whiteside; John M Kirkwood; David H Lawson
Journal:  Clin Cancer Res       Date:  2017-05-23       Impact factor: 12.531

3.  Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.

Authors:  María E Rodriguez-Ruiz; Inmaculada Rodriguez; Saray Garasa; Benigno Barbes; Jose Luis Solorzano; Jose Luis Perez-Gracia; Sara Labiano; Miguel F Sanmamed; Arantza Azpilikueta; Elixabet Bolaños; Alfonso R Sanchez-Paulete; M Angela Aznar; Ana Rouzaut; Kurt A Schalper; Maria Jure-Kunkel; Ignacio Melero
Journal:  Cancer Res       Date:  2016-08-22       Impact factor: 12.701

Review 4.  Evolving synergistic combinations of targeted immunotherapies to combat cancer.

Authors:  Ignacio Melero; David M Berman; M Angela Aznar; Alan J Korman; José Luis Pérez Gracia; John Haanen
Journal:  Nat Rev Cancer       Date:  2015-08       Impact factor: 60.716

Review 5.  Current understanding of interactions between nanoparticles and the immune system.

Authors:  Marina A Dobrovolskaia; Michael Shurin; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

Review 6.  Therapeutic cancer vaccines.

Authors:  Cornelis J M Melief; Thorbald van Hall; Ramon Arens; Ferry Ossendorp; Sjoerd H van der Burg
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

Review 7.  The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors.

Authors:  Barbara Seliger
Journal:  J Immunotoxicol       Date:  2014-01-30       Impact factor: 3.000

8.  Nivolumab plus ipilimumab in advanced melanoma.

Authors:  Jedd D Wolchok; Harriet Kluger; Margaret K Callahan; Michael A Postow; Naiyer A Rizvi; Alexander M Lesokhin; Neil H Segal; Charlotte E Ariyan; Ruth-Ann Gordon; Kathleen Reed; Matthew M Burke; Anne Caldwell; Stephanie A Kronenberg; Blessing U Agunwamba; Xiaoling Zhang; Israel Lowy; Hector David Inzunza; William Feely; Christine E Horak; Quan Hong; Alan J Korman; Jon M Wigginton; Ashok Gupta; Mario Sznol
Journal:  N Engl J Med       Date:  2013-06-02       Impact factor: 91.245

Review 9.  Systematic evaluation of immune regulation and modulation.

Authors:  David F Stroncek; Lisa H Butterfield; Michael A Cannarile; Madhav V Dhodapkar; Tim F Greten; Jean Charles Grivel; David R Kaufman; Heidi H Kong; Firouzeh Korangy; Peter P Lee; Francesco Marincola; Sergio Rutella; Janet C Siebert; Giorgio Trinchieri; Barbara Seliger
Journal:  J Immunother Cancer       Date:  2017-03-21       Impact factor: 13.751

10.  HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.

Authors:  Mariette I E van Poelgeest; Marij J P Welters; Edith M G van Esch; Linda F M Stynenbosch; Gijs Kerpershoek; Els L van Persijn van Meerten; Muriel van den Hende; Margriet J G Löwik; Dorien M A Berends-van der Meer; Lorraine M Fathers; A Rob P M Valentijn; Jaap Oostendorp; Gert Jan Fleuren; Cornelis J M Melief; Gemma G Kenter; Sjoerd H van der Burg
Journal:  J Transl Med       Date:  2013-04-04       Impact factor: 5.531
View more
  1 in total

Review 1.  Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen.

Authors:  Richard Harrop; Eric O'Neill; Peter L Stern
Journal:  Ther Adv Vaccines Immunother       Date:  2019-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.